215 related articles for article (PubMed ID: 23299798)
1. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
[TBL] [Abstract][Full Text] [Related]
2. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.
Bondanza A; Valtolina V; Magnani Z; Ponzoni M; Fleischhauer K; Bonyhadi M; Traversari C; Sanvito F; Toma S; Radrizzani M; La Seta-Catamancio S; Ciceri F; Bordignon C; Bonini C
Blood; 2006 Mar; 107(5):1828-36. PubMed ID: 16293601
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
[TBL] [Abstract][Full Text] [Related]
5. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation.
Hashimoto H; Kitano S; Yamagata S; Miyagi Maeshima A; Ueda R; Ito A; Tada K; Fuji S; Yamashita T; Tomura D; Nukaya I; Mineno J; Fukuda T; Mori S; Takaue Y; Heike Y
Cytotherapy; 2015 Dec; 17(12):1820-30. PubMed ID: 26452983
[TBL] [Abstract][Full Text] [Related]
6. IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.
Kaneko S; Mastaglio S; Bondanza A; Ponzoni M; Sanvito F; Aldrighetti L; Radrizzani M; La Seta-Catamancio S; Provasi E; Mondino A; Nagasawa T; Fleischhauer K; Russo V; Traversari C; Ciceri F; Bordignon C; Bonini C
Blood; 2009 Jan; 113(5):1006-15. PubMed ID: 18978209
[TBL] [Abstract][Full Text] [Related]
7. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease.
Liu J; Anderson BE; Robert ME; McNiff JM; Emerson SG; Shlomchik WD; Shlomchik MJ
Blood; 2001 Dec; 98(12):3367-75. PubMed ID: 11719376
[TBL] [Abstract][Full Text] [Related]
8. IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors.
Bondanza A; Hambach L; Aghai Z; Nijmeijer B; Kaneko S; Mastaglio S; Radrizzani M; Fleischhauer K; Ciceri F; Bordignon C; Bonini C; Goulmy E
Blood; 2011 Jun; 117(24):6469-78. PubMed ID: 21531977
[TBL] [Abstract][Full Text] [Related]
9. Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor.
Ciceri F; Bordignon C
Int J Hematol; 2002 Nov; 76(4):305-9. PubMed ID: 12463592
[TBL] [Abstract][Full Text] [Related]
10. Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.
Zhan H; Gilmour K; Chan L; Farzaneh F; McNicol AM; Xu JH; Adams S; Fehse B; Veys P; Thrasher A; Gaspar H; Qasim W
PLoS One; 2013; 8(10):e77106. PubMed ID: 24204746
[TBL] [Abstract][Full Text] [Related]
11. Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Aycox PG; Stephens C; McCue LD; Champlin RE; Marini FC
Exp Hematol; 2007 May; 35(5):842-53. PubMed ID: 17577932
[TBL] [Abstract][Full Text] [Related]
12. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
13. Application of donor lymphocytes expressing a suicide gene for early GVL induction and later control of GVH reactions after bone-marrow transplantation.
Bondanza A; Ciceri F; Bonini C
Methods Mol Med; 2005; 109():475-86. PubMed ID: 15585940
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
[TBL] [Abstract][Full Text] [Related]
15. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells.
Adachi Y; Sakai T; Terakura S; Shiina T; Suzuki S; Hamana H; Kishi H; Sasazuki T; Arase H; Hanajiri R; Goto T; Nishida T; Murata M; Kiyoi H
Int J Hematol; 2022 Mar; 115(3):371-381. PubMed ID: 35037229
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2018; 9():3041. PubMed ID: 30619371
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation and cellular therapy.
Kolb HJ
HLA; 2017 May; 89(5):267-277. PubMed ID: 28371460
[TBL] [Abstract][Full Text] [Related]
19. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
